1.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)

Lau, G, Yu, ML, Wong     More...

Lau, G, Yu, ML, Wong, GC, Thompson, A, Ghazinian, H, Hou, JL, Piratvisuth, T, Jia, JD, Mizokami, M, Cheng, G, Chen, GF, Liu, ZW, Baatarkhuu, O, Cheng, AL, Ng, WL, Lau, P, Mok, T, Chang, JM, Hamid, S, Dokmeci, AK, Gani, RA, Payawal, DA, Chow, P, Park, JW, Strasser, SI, Mohamed, R, Win, KM, Tanwandee, T, Sarin, SK, Omata, M     Less

HEPATOLOGY INTERNATIONAL[1936-0533], Published 2022, Volume 16, Issue 2, Pages 486-487

收錄情况： WOS SCOPUS

WOS核心合集引用: 1  2022影響因子:  6.6  发表年影響因子:  6.6 

2.Achieving WHO target of HCV control in Hong Kong: challenges and strategies

Wang, YD, Cheng, G,     More...

Wang, YD, Cheng, G, Lau, G     Less

GLOBAL HEALTH & MEDICINE[2434-9186], Published 2021, Volume 3, Issue 5, Pages 276-282

收錄情况： WOS

WOS核心合集引用: 0  2022影響因子:  2.6 

3.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

Lau, G, Yu, ML, Wong     More...

Lau, G, Yu, ML, Wong, G, Thompson, A, Ghazinian, H, Hou, JL, Piratvisuth, T, Jia, JD, Mizokami, M, Cheng, G, Chen, GF, Liu, ZW, Baatarkhuu, O, Cheng, AL, Ng, WL, Lau, P, Mok, T, Chang, EM, Hamid, S, Dokmeci, AK, Gani, RA, Payawal, DA, Chow, P, Park, JW, Strasser, SI, Mohamed, R, Win, KM, Tawesak, T, Sarin, SK, Omata, M     Less

HEPATOLOGY INTERNATIONAL[1936-0533], Published 2021, Volume 15, Issue 5, Pages 1031-1048

收錄情况： WOS SCOPUS

WOS核心合集引用: 52  2022影響因子:  6.6  发表年影響因子:  9.046 

4.Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"

Ji, D, Cheng, G, Lau     More...

Ji, D, Cheng, G, Lau, G     Less

JOURNAL OF HEPATOLOGY[0168-8278], Published 2021, Volume 74, Issue 2, Pages 484-485

收錄情况： WOS SCOPUS

WOS核心合集引用: 8  2022影響因子:  25.7  发表年影響因子:  30.083 

5.Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19

Ji, D, Zhang, MJ, Qi     More...

Ji, D, Zhang, MJ, Qin, EQ, Zhang, LQ, Xu, J, Wang, YD, Cheng, G, Wang, F, Lau, G     Less

METABOLISM-CLINICAL AND EXPERIMENTAL[0026-0495], Published 2021, Volume 115,

收錄情况： WOS SCOPUS

WOS核心合集引用: 17  2022影響因子:  9.8  发表年影響因子:  13.934 

6.The CALL Score for Predicting Outcomes in Patients With COVID-19 Reply

Ji, D, Qin, EQ, Zhan     More...

Ji, D, Qin, EQ, Zhang, DW, Cheng, G, Lau, G     Less

CLINICAL INFECTIOUS DISEASES[1058-4838], Published 2021, Volume 72, Issue 1, Pages 183-183

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  11.8  发表年影響因子:  20.999 

7.The Inherent Problems With the Generalizability of the CALL Score: Towards Reliable Clinical Prediction Models for Coronavirus Disease 2019 (COVID-19) Reply

Ji, D, Qin, EQ, Zhan     More...

Ji, D, Qin, EQ, Zhang, DW, Cheng, G, Lau, G     Less

CLINICAL INFECTIOUS DISEASES[1058-4838], Published 2021, Volume 73, Issue 9, Pages E2819-E2819

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2022影響因子:  11.8  发表年影響因子:  20.999 

8.Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

DongJi, Guo-feng Che     More...

DongJi, Guo-feng Chen, Xiao-xia Niu, Mingjie Zhang, Cheng Wang, Qing Shao, Vanessa Wu, Yudong Wang, Gregory Cheng, Selwyn J. Hurwitz, Raymond F. Schinazi, George Lau     Less

Metabolism Open[2589-9368], Published 2021, Volume 10,

9.Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening

Shao, FY, Lyu, XY, M     More...

Shao, FY, Lyu, XY, Miao, K, Xie, LS, Wang, HT, Xiao, H, Li, J, Chen, Q, Ding, RB, Chen, P, Xing, FQ, Zhang, X, Luo, GH, Zhu, WL, Cheng, G, Lon, NW, Martin, SE, Wang, GY, Chen, GK, Dai, YL, Deng, CX     Less

ADVANCED SCIENCE[2198-3844], Published 2020, Volume 7, Issue 23,

收錄情况： WOS SCOPUS

WOS核心合集引用: 10  2022影響因子:  15.1  发表年影響因子:  16.806 

10.Safety and efficacy of eltrombopag plus pulsed dexamethasone as first-line therapy for immune thrombocytopenia

Zhang, LQ, Zhang, MJ     More...

Zhang, LQ, Zhang, MJ, Du, X, Cheng, YF, Cheng, G     Less

BRITISH JOURNAL OF HAEMATOLOGY[0007-1048], Published 2020, Volume 189, Issue 2, Pages 369-378

收錄情况： WOS SCOPUS

WOS核心合集引用: 30  2022影響因子:  6.5  发表年影響因子:  6.998 

More...

1.Identity tags

Cheng Gregory Yin Mi     More... Cheng Gregory Yin Ming     Less

專利權人: Chu Victor Ka Shun     More... Chu Victor Ka Shun     Less

申請號: US09140068 申請日: 1998/8/18

公開（公告）號: US6092321A 公開（公告）日期: 2000/7/25

IPC分類號: G09F3/14; G09F3/00

法律狀態: 失效

同族信息: US6092321A